Global Cannabis Industry Round-Up
June 2026 Edition
Global Cannabis Industry Round-Up
Across North America and Europe, June delivered a clear reminder that the cannabis industry is still moving forward.
Medical programs are launching. Regulations are evolving. Cultivation capacity is expanding. And supply chains are becoming a bigger part of the conversation.
The industry is entering a more mature phase. One where operational discipline matters more than rapid expansion, and long-term sustainability is replacing growth-at-all-costs thinking.
From new medical markets opening in the United States to growing infrastructure investments across Europe, the focus is increasingly shifting from possibility to execution.
While every market remains at a different stage of development, one trend is becoming increasingly clear:
The global cannabis industry is growing up.
Canada
Signs of Stabilization in a Mature Market
Canada remains one of the most competitive cannabis markets in the world, but June offered signs that some operators may finally be finding firmer footing.
One of the more notable developments came from Connecticut's neighbouring market insights, where cannabis sales increased despite rising average prices, reinforcing a trend many operators have been hoping to see: consumers are becoming less price-sensitive when products, brands, and retail experiences deliver value.
For Canadian operators facing years of pricing compression, that's an encouraging signal.
Across the country, businesses continue focusing on:
Margin protection
Operational efficiency
Brand differentiation
International export opportunities
Strategic talent acquisition
Provincial Updates
Ontario – Competition remains intense, but stronger operators continue investing in customer experience, loyalty programs, and differentiated product portfolios.
Alberta – Retailers continue advocating for increased operational flexibility as market maturity reshapes growth expectations.
British Columbia – Craft producers remain focused on premium positioning and product quality as consumers increasingly seek differentiated offerings.
Québec – The SQDC's tightly regulated model continues producing stable results while maintaining its public-health-focused approach.
International Exports - Canadian licensed producers continue benefiting from growing European demand, particularly in Germany's rapidly expanding medical market. As domestic growth stabilizes, exports are becoming an increasingly important revenue driver for some of Canada's largest operators and reinforcing the country's position as a key supplier to global medical cannabis markets.
United States
State-by-State Progress Continues
The U.S. cannabis industry remains fragmented, but June demonstrated once again that meaningful progress doesn't require federal reform.
Several states made significant moves that could influence operators, investors, and employers alike.
State Updates
Nebraska - After years of delays and legal uncertainty, Nebraska's first medical cannabis cultivator received approval to begin growing. While the market remains in its early stages, the decision represents a major milestone and signals the state's medical program is finally beginning to take shape.
Massachusetts - Massachusetts regulators approved measures to cap cannabis cultivation while simultaneously expanding retail opportunities. The move reflects a broader trend seen across mature markets: balancing supply with demand while creating opportunities for sustainable retail growth.
Illinois - Illinois lawmakers moved to bring intoxicating hemp-derived THC products under the state's regulated cannabis framework. The decision highlights the growing pressure regulators face to address hemp-derived cannabinoids and create more consistent oversight across product categories.
Alabama - After years of regulatory setbacks and legal disputes, Alabama's medical cannabis market finally opened. While rollout challenges remain, operators and patients are now beginning to see long-awaited progress.
New York - New York continued efforts to crack down on illicit operators while supporting the expansion of its regulated retail market. The state remains one of the industry's most closely watched examples of balancing enforcement with legal market development.
Federal Reform Watch - While meaningful federal reform remains uncertain, discussions around cannabis rescheduling continue to be closely monitored by operators, investors, and employers. Any movement at the federal level could have significant implications for capital access, taxation, and long-term industry growth.
Tribal Cannabis Markets - Beyond individual market growth, tribal cannabis enterprises continue expanding through new partnerships, retail operations, and discussions around interstate commerce. As regulatory frameworks evolve, tribal nations are expected to play an increasingly important role in the future U.S. cannabis landscape.
Europe
Infrastructure Becomes the New Growth Story
Europe's cannabis market continues evolving, but June highlighted an important shift:
The conversation is moving beyond legalization and toward infrastructure.
As patient demand grows and medical programs expand, attention is increasingly turning toward supply chains, cultivation standards, and pharmaceutical-grade production systems.
Country Updates
Germany
Germany remains the center of gravity for European cannabis growth, with medical demand continuing to accelerate and placing new pressure on supply networks across the continent.
United Kingdom
Industry stakeholders are increasingly focused on strengthening medical cannabis supply chains to support future patient growth and ensure product consistency.
Europe-Wide Development
A major milestone was reached with the launch of Europe's first single-site cannabis plant health facility. The initiative is expected to support disease prevention, plant health monitoring, cultivation research, and production quality across the region.
Portugal
Portugal continues reinforcing its position as one of Europe's leading cultivation and export hubs, supplying medical markets throughout the EU.
France & Czech Republic
Both countries continue progressing through regulatory discussions and pilot programs, maintaining momentum toward broader market evolution.
Talent Implications
Expertise Matters More Than Ever
As markets mature, hiring priorities continue evolving.
The industry's next growth phase will require leaders capable of managing complexity, not just expansion.
We're continuing to see demand for:
Regulatory and compliance professionals
Cultivation and production leaders
Supply chain and logistics specialists
Finance and restructuring executives
Commercial leaders with proven operational experience
International business development talent
At the same time, candidates continue facing:
Longer hiring cycles
Increased competition
Greater emphasis on measurable business impact
Higher expectations around adaptability and execution
Closing Thought
June reinforced something we've been saying for quite some time:
The cannabis industry is still growing.
It's just growing differently.
Across Canada, the United States, and Europe, operators are becoming more sophisticated, regulators are refining frameworks, and infrastructure is finally beginning to catch up with demand.
The companies gaining ground today aren't necessarily the ones making the most noise.
They're the ones:
Building stronger foundations
Investing in operational excellence
Navigating regulation strategically
Hiring people who can execute
The next chapter of the cannabis industry won't be defined by hype.
It will be defined by who can build businesses that last.